High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer's disease in human cerebrospinal fluid

Ronald C. Hendrickson; Anita Y.H. Lee; Qinghua Song; Andy Liaw; Matt Wiener; Cloud P. Paweletz; Jeffrey L. Seeburger; Jenny Li; Fanyu Meng; Ekaterina G. Deyanova; Matthew T. Mazur; Robert E. Settlage; Xuemei Zhao; Katie Southwick; Yi Du; Dan Holder; Jeffrey R. Sachs; Omar F. Laterza; Aimee Dallob; Derek L. Chappell; Karen Snyder; Vijay Modur; Elizabeth King; Catharine Joachim; Andrey Y. Bondarenko; Mark Shearman; Keith A. Soper; A. David Smith; William Z. Potter; Ken S. Koblan; Alan B. Sachs; Nathan A. Yates

doi:10.1371/journal.pone.0135365

Back

High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer's disease in human cerebrospinal fluid

Journal article

Peer reviewed

High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer's disease in human cerebrospinal fluid

Ronald C. Hendrickson, Anita Y.H. Lee, Qinghua Song, Andy Liaw, Matt Wiener, Cloud P. Paweletz, Jeffrey L. Seeburger, Jenny Li, Fanyu Meng, Ekaterina G. Deyanova, …

PloS one, Vol.10(8), p.e0135365

2015-08-13

DOI: https://doi.org/10.1371/journal.pone.0135365

PMID: 26270474

Appears in UM Open Access Research Published in PloS

Files and links (1)

url

https://doi.org/10.1371/journal.pone.0135365View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer's disease in human cerebrospinal fluid
Creators: Ronald C. Hendrickson - Merck & Co., Inc., Rahway, NJ, USA
Anita Y.H. Lee - Merck & Co., Inc., Rahway, NJ, USA
Qinghua Song - Merck & Co., Inc., Rahway, NJ, USA
Andy Liaw - Merck & Co., Inc., Rahway, NJ, USA
Matt Wiener - Merck & Co., Inc., Rahway, NJ, USA
Cloud P. Paweletz - Merck & Co., Inc., Rahway, NJ, USA
Jeffrey L. Seeburger - Merck & Co., Inc., Rahway, NJ, USA
Jenny Li - Merck & Co., Inc., Rahway, NJ, USA
Fanyu Meng - Merck & Co., Inc., Rahway, NJ, USA
Ekaterina G. Deyanova - Merck & Co., Inc., Rahway, NJ, USA
Matthew T. Mazur - Merck & Co., Inc., Rahway, NJ, USA
Robert E. Settlage - Merck & Co., Inc., Rahway, NJ, USA
Xuemei Zhao - Merck & Co., Inc., Rahway, NJ, USA
Katie Southwick - Merck & Co., Inc., Rahway, NJ, USA
Yi Du - Merck & Co., Inc., Rahway, NJ, USA
Dan Holder - United States Military Academy
Jeffrey R. Sachs - Merck & Co., Inc., Rahway, NJ, USA
Omar F. Laterza - Merck & Co., Inc., Rahway, NJ, USA
Aimee Dallob - Merck & Co., Inc., Rahway, NJ, USA
Derek L. Chappell - Merck & Co., Inc., Rahway, NJ, USA
Karen Snyder - Merck & Co., Inc., Rahway, NJ, USA
Vijay Modur - Merck & Co., Inc., Rahway, NJ, USA
Elizabeth King - University of Oxford
Catharine Joachim - University of Oxford
Andrey Y. Bondarenko - Rosetta Stone
Mark Shearman - Merck & Co., Inc., Rahway, NJ, USA
Keith A. Soper - United States Military Academy
A. David Smith - University of Oxford
William Z. Potter - Merck & Co., Inc., Rahway, NJ, USA
Ken S. Koblan - Merck & Co., Inc., Rahway, NJ, USA
Alan B. Sachs - Merck & Co., Inc., Rahway, NJ, USA
Nathan A. Yates - Merck & Co., Inc., Rahway, NJ, USA
Publication Details: PloS one, Vol.10(8), p.e0135365
Grant note: Merck
Academic Unit: Miller School of Medicine; Microbiology and Immunology Research; Biochemistry & Molecular Biology Research
Language: English
Resource Type: Journal article
PMID: 26270474
Record Identifier: 991032906008702976